3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Lung Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Tobacco Use Disorder
1
Recurrence
1
Precancerous Conditions
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hirschsprung Disease
1
Glioma
1
Ganglion Cysts
1
Gallbladder Neoplasms
1
Endometrial Neoplasms
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Immunohistochemistry
×
Clear all
NCT02015728
2016-12-15
SEED
Seattle Children's Hospital
Phase NA
Unknown
20 enrolled